Eckhart Kaempgen

4.3k total citations
21 papers, 1.0k citations indexed

About

Eckhart Kaempgen is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Eckhart Kaempgen has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Eckhart Kaempgen's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Eckhart Kaempgen is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Eckhart Kaempgen collaborates with scholars based in Germany, Belgium and United States. Eckhart Kaempgen's co-authors include Philippe Demaerel, Stefan Rutkowski, Frank Van Calenbergh, Johannes Wolff, Steven De Vleeschouwer, Gerold Schuler, Monika Warmuth‐Metz, Stefaan W. Van Gool, Raf Sciot and Beatrice Schuler‐Thurner and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Eckhart Kaempgen

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eckhart Kaempgen Germany	13	591	578	471	204	116	21	1.0k
Yutaka Kawakami Japan	17	672 1.1×	452 0.8×	331 0.7×	52 0.3×	69 0.6×	31	1.2k
Julie Stewart United States	17	303 0.5×	252 0.4×	266 0.6×	34 0.2×	39 0.3×	26	757
A Houghton United States	9	386 0.7×	632 1.1×	534 1.1×	32 0.2×	17 0.1×	11	1.1k
Henrik Jespersen Sweden	15	310 0.5×	425 0.7×	349 0.7×	18 0.1×	205 1.8×	25	787
Volker Lennerz Germany	17	941 1.6×	937 1.6×	646 1.4×	47 0.2×	9 0.1×	28	1.5k
Jean-Michel Vernes United States	12	462 0.8×	552 1.0×	613 1.3×	63 0.3×	17 0.1×	15	1.3k
Kay Stubenrauch Germany	16	446 0.8×	224 0.4×	757 1.6×	69 0.3×	238 2.1×	33	1.4k
Christopher R. Zito United States	17	279 0.5×	745 1.3×	542 1.2×	124 0.6×	8 0.1×	29	1.3k
Jean-Pierre Abastado France	15	875 1.5×	718 1.2×	419 0.9×	23 0.1×	25 0.2×	19	1.4k

Countries citing papers authored by Eckhart Kaempgen

Since Specialization

Citations

This map shows the geographic impact of Eckhart Kaempgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eckhart Kaempgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eckhart Kaempgen more than expected).

Fields of papers citing papers by Eckhart Kaempgen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eckhart Kaempgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eckhart Kaempgen. The network helps show where Eckhart Kaempgen may publish in the future.

Co-authorship network of co-authors of Eckhart Kaempgen

This figure shows the co-authorship network connecting the top 25 collaborators of Eckhart Kaempgen. A scholar is included among the top collaborators of Eckhart Kaempgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eckhart Kaempgen. Eckhart Kaempgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wildner, D, Lucie Heinzerling, M. E. Scheulen, et al.. (2021). Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US). Journal of Cancer Research and Clinical Oncology. 148(4). 955–965. 2 indexed citations

Scheulen, M. E., Eckhart Kaempgen, Ulrich Keilholz, et al.. (2017). STREAM: A randomized discontinuation, blinded, placebo-controlled phase II study of sorafenib (S) treatment of chemonaïve patients (pts) with metastatic uveal melanoma (MUM).. Journal of Clinical Oncology. 35(15_suppl). 9511–9511. 11 indexed citations

Groß, Stefanie, Volker Lennerz, Elisa Gallerani, et al.. (2015). Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers. Cancer Immunology Research. 4(1). 18–25. 18 indexed citations

Leyvraz, Serge, Sophie Piperno‐Neumann, Stefan Suciu, et al.. (2014). Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial. Annals of Oncology. 25(3). 742–746. 92 indexed citations

Lennerz, Volker, Stefanie Groß, Elisa Gallerani, et al.. (2014). Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors. Cancer Immunology Immunotherapy. 63(4). 381–394. 93 indexed citations

Srinivas, Mangala, Ignacio Melero, Eckhart Kaempgen, Carl G. Figdor, & I. Jolanda M. de Vries. (2013). Cell tracking using multimodal imaging. Contrast Media & Molecular Imaging. 8(6). 432–438. 15 indexed citations

Heinzerling, Lucie, Eckhart Kaempgen, Petra Keikavoussi, et al.. (2013). Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice. British Journal of Cancer. 108(10). 2164–2171. 68 indexed citations

Hauschild, Axel, Jean‐Jacques Grob, Lev Demidov, et al.. (2013). An update on BREAK-3, a phase III, randomized trial: Dabrafenib (DAB) versus dacarbazine (DTIC) in patients with BRAF V600E-positive mutation metastatic melanoma (MM).. Journal of Clinical Oncology. 31(15_suppl). 9013–9013. 89 indexed citations

Voskens, Caroline, Alexander Cavallaro, Michael Erdmann, et al.. (2012). Anti–Cytotoxic T-Cell Lymphocyte Antigen-4–Induced Regression of Spinal Cord Metastases in Association With Renal Failure, Atypical Pneumonia, Vision Loss, and Hearing Loss. Journal of Clinical Oncology. 30(33). e356–e357. 35 indexed citations

10.

Leyvraz, Serge, Stefan Suciu, Sophie Piperno‐Neumann, et al.. (2012). Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma: Final results of the EORTC 18021 study.. Journal of Clinical Oncology. 30(15_suppl). 8532–8532. 8 indexed citations

11.

Hesse, Andrea, Ilka Knippertz, Eckhart Kaempgen, et al.. (2011). Human dendritic cells efficiently phagocytose adenoviral oncolysate but require additional stimulation to mature. International Journal of Cancer. 130(7). 1682–1694. 5 indexed citations

12.

Lennerz, Volker, Elisa Gallerani, Cristiana Sessa, et al.. (2011). First-in-human trial focusing on the immunologic effects of the survivin-derived multiepitope vaccine EMD640744.. Journal of Clinical Oncology. 29(15_suppl). 2515–2515. 2 indexed citations

13.

Erfurt‐Berge, Cornelia & Eckhart Kaempgen. (2010). Melanom und Schwangerschaft. Der Hautarzt. 61(12). 1040–1045. 2 indexed citations

14.

Janetzki, Sylvia, Leah Price, Cedrik M. Britten, et al.. (2009). Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells. Cancer Immunology Immunotherapy. 59(4). 609–618. 44 indexed citations

15.

Vleeschouwer, Steven De, Steffen Fieuws, Stefan Rutkowski, et al.. (2008). Postoperative Adjuvant Dendritic Cell–Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme. Clinical Cancer Research. 14(10). 3098–3104. 205 indexed citations

16.

Wobser, Marion, Heike Voigt, Roland Houben, et al.. (2006). Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression. Cancer Immunology Immunotherapy. 56(7). 1017–1024. 62 indexed citations

17.

Berger, Thomas, Erwin Strasser, Richard J. Smith, et al.. (2005). Efficient elutriation of monocytes within a closed system (Elutra™) for clinical-scale generation of dendritic cells. Journal of Immunological Methods. 298(1-2). 61–72. 87 indexed citations

18.

Vleeschouwer, Steven De, Frank Van Calenbergh, Philippe Demaerel, et al.. (2004). Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Journal of Neurosurgery Pediatrics. 100(5). 492–497. 64 indexed citations

19.

Rutkowski, Stefan, Steven De Vleeschouwer, Eckhart Kaempgen, et al.. (2004). Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study. British Journal of Cancer. 91(9). 1656–1662. 137 indexed citations

20.

Kaempgen, Eckhart, et al.. (2003). Late‐type allergy to Ultravist® (iopromid). Allergy. 58(3). 261–262. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact